학술논문
Telomere shortening, clonal evolution and disease progression in myelodysplastic syndrome patients with 5q deletion treated with lenalidomide.
Document Type
Letter
Author
Source
Subject
*LETTERS to the editor
*MYELODYSPLASTIC syndromes
*
Language
ISSN
0887-6924
Abstract
A letter to the editor in response to the article "Telomere shortening, clonal evolution and disease progression in myelodysplastic syndrome patients with 5q deletion treated with lenalidomide," published in the online July 29, 2011 issue of the journal "Leukemia" is presented.